Anti-TNF Treatment and Risk of Atrial Fibrillation in Inflammatory Bowel Disease Patients

被引：0
|
作者：
Cohen, Y. [1 ]
Fischman, M. [1 ]
Waterman, M. [2 ]
Dolnikov, K. [3 ]
Azzam, Z. S. [3 ]
Ghersin, I. [2 ]
机构：
[1] Hebrew Univ Jerusalem, Dept Mil Med, Fac Med, Jerusalem, Israel
[2] Rambam Hlth Care Campus, Dept Gastroenterol, Haifa, Israel
[3] Rambam Hlth Care Campus, Dept Internal Med B, Haifa, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P552
引用
收藏
页码：681 / 681
页数：1
相关论文
共 50 条
  • [31] Inflammatory bowel disease: anti-TNF strategies and beyond
    Hoffmann, JC
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S76 - S78
  • [32] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [33] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [34] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [35] How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
    Culver, Emma L.
    Travis, Simon P. L.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 198 - 218
  • [36] Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
    Sochal, Marcin
    Fichna, Jakub
    Gabryelska, Agata
    Talar-Wojnarowska, Renata
    Bialasiewicz, Piotr
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [37] Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment
    Wauters, Lucas
    Billiet, Thomas
    Papamichael, Konstantinos
    Ballet, Vera
    Joniau, Steven
    Verschueren, Patrick
    Silversmit, Geert
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (01) : 84 - 90
  • [38] Treatment Adherence of Anti-TNF Drugs in the Patients with Inflammatory Bowel Disease: A Scale Development Study
    Basak, Nur
    Uran, Berna Nilgun Ozgursoy
    Yuksel, Elif Saritas
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (04): : 336 - +
  • [39] Increased Risk of Preeclampsia in Women With Inflammatory Bowel Disease on Anti-TNF Therapy
    Kattah, Andrea
    Becker, Brenda
    Kane, Sunanda
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S444 - S444
  • [40] Mucosal gene expression changes induced by anti-TNF treatment in inflammatory bowel disease patients
    Milanesi, Elena
    Dobre, Maria
    Manuc, Teodora E.
    Becheanu, Gabriel
    Tieranu, Cristian G.
    Ionescu, Elena M.
    Manuc, Mircea
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (06) : 831 - 836
12345